Citral #13

Description

**Citral #13** is a premium hybrid strain developed by DNA Genetics, representing a refined phenotype selection from their original Citral line. This strain showcases a perfect balance between its 60% indica and 40% sativa heritage, resulting in a versatile and potent experience. **Genetics & Profile:** As a phenotype of the classic Citral (a cross of Citral #1 and Citral #2, both landrace sativas from South America and India), Citral #13 has been stabilized to emphasize its most desirable traits. It features a remarkably high THC content averaging 22.5%, with minimal CBD but notable CBG presence at 0.8%, contributing to its therapeutic potential. **Terpene Profile:** The dominant terpene is **limonene**, which delivers the signature citrus explosion, complemented by **myrcene** for relaxation and **caryophyllene** for anti-inflammatory benefits. This combination creates a complex aromatic bouquet that translates directly to flavor. **Effects & Medical Use:** The effects begin with a cerebral, **euphoric** and **creative** lift characteristic of its sativa side, which smoothly transitions into a deeply **relaxed** and physically calming state without heavy sedation. This makes it excellent for daytime or evening use. Medically, it's particularly effective for managing **stress**, **anxiety**, **chronic pain**, and **inflammation**. **Cultivation Notes:** With a **moderate** growing difficulty, Citral #13 rewards experienced growers. It develops a robust structure with **average** height and responds well to training techniques like SCROG or topping. The 9-week flowering period yields **high** quantities of dense, resin-coated buds that emit a powerful citrus-pungent aroma during the final weeks. Growers should ensure good air circulation to prevent mold in its dense colas.